Does Lithium Interact with Acetazolamide Extended Release?
Lithium and Acetazolamide Extended Release have a moderate drug interaction according to U.S. FDA drug labeling data. Acetazolamide increases lithium excretion, which may lead to decreased lithium levels. The mechanism involves increased lithium excretion. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Moderate
- Acetazolamide Extended Release Class
- Carbonic Anhydrase Inhibitor
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
How This Interaction Works
The interaction between Lithium and Acetazolamide Extended Release occurs because increased lithium excretion. Clinically, this means acetazolamide increases lithium excretion, which may lead to decreased lithium levels. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.
What To Tell Your Doctor or Pharmacist
If you are taking Lithium and your doctor is considering prescribing Acetazolamide Extended Release (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider